Axogen targets at least 18% revenue growth in 2026 as BLA milestone strengthens market position [Seeking Alpha]
Axogen, Inc. (AXGN)
Last axogen, inc. earnings: 2/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.axogeninc.com
Company Research
Source: Seeking Alpha
Michael Dale, President and CEO, highlighted, "2025 was a year of significant achievement for Axogen, both financially and strategically and one that positions us well for durable growth in the years ahead." He reported Q4 Quick Insights Axogen expects at least 18% revenue growth in 2026 following the FDA approval of Avance, with stable gross margins and emphasis on disciplined commercial execution and market expansion. The transition will create product cost pressure on gross margins in 2026, with margins expected to stabilize within 74-76% and improvement anticipated in 2027; short-term one-time expenses due to the FDA approval and stock-based compensation will temporarily lower margins. Axogen plans significant sales force expansion in Breast and Extremities, intends to further advance market development, and is investing in professional education, with commercial hiring aimed at driving durable growth and positioning for wider adoption of its products. More Trending News
Show less
Read more
Impact Snapshot
Event Time:
AXGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXGN alerts
High impacting Axogen, Inc. news events
Weekly update
A roundup of the hottest topics
AXGN
News
- Axogen (AXGN) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- AxoGen Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
- AxoGen (NASDAQ:AXGN) had its price target raised by analysts at Citizens Jmp from $34.00 to $42.00. They now have a "market outperform" rating on the stock.MarketBeat
- AxoGen: Q4 Earnings Snapshot [Yahoo! Finance]Yahoo! Finance
- Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
AXGN
Earnings
- 2/24/26 - Beat
AXGN
Sec Filings
- 2/24/26 - Form 4
- 2/24/26 - Form 10-K
- 2/24/26 - Form 8-K
- AXGN's page on the SEC website